CTIC : Insider Transactions for Cti Biopharma Corporation

Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	5,000
Total Buy Value	$0	$0	$0	$27,500
Total People Bought	0	0	0	1
Total Buy Transactions	0	0	0	1
Total Shares Sold	0	0	0	9,922,851
Total Sell Value	$0	$0	$0	$60,660,378
Total People Sold	0	0	0	5
Total Sell Transactions	0	0	0	29
End Date	2024-02-18	2023-11-17	2023-05-19	2022-05-19

Adjust Filter Settings

Records found: 742

Page 17 of 30

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Bianco James A

CEO

• • –

2011-09-30

$1.04

$10,400

D/D

(10,000)

2,162,295

Tuckson Reed Vaughn

Director

– • –

2011-09-22

$0.00

D/D

18,000

Singer Jack W

EVP, Chief Medical Officer

• • –

2011-09-21

$1.02

$7,745

D/D

(7,593)

1,026,500

Philips Craig

President

• – –

2011-09-21

$1.02

$7,745

D/D

(7,593)

1,549,811

Bianco James A

CEO

• • –

2011-09-21

$1.05

$79,919

D/D

(76,041)

2,172,295

Eramian Daniel G

EVP, Corporate Communications

• – –

2011-09-21

$1.02

$7,745

D/D

(7,593)

752,627

Bianco Louis A

EVP, Finance & Administration

• – –

2011-09-21

$1.02

$5,620

D/D

(5,510)

986,935

Bianco James A

CEO

• • –

2011-09-16

$1.11

$55,550

D/D

(50,000)

2,248,336

Bianco James A

CEO

• • –

2011-08-26

$1.12

$33,600

D/D

(30,000)

2,298,336

Bianco James A

CEO

• • –

2011-07-29

$1.34

$13,400

D/D

(10,000)

2,328,336

Bianco James A

CEO

• • –

2011-05-13

$0.28

$83,100

D/D

(300,000)

14,030,017

Philips Craig

President

• – –

2011-04-26

$0.39

$1,032

D/D

(2,620)

9,344,428

Bianco James A

CEO

• • –

2011-03-25

$0.39

$143,762

D/D

(368,621)

11,830,017

Bianco Louis A

EVP, Finance & Administration

• – –

2011-03-25

$0.38

$40,120

D/D

(105,579)

5,704,670

Eramian Daniel G

EVP, Corporate Communications

• – –

2011-03-25

$0.38

$40,120

D/D

(105,579)

4,311,320

Philips Craig

President

• – –

2011-03-25

$0.38

$80,240

D/D

(211,158)

9,097,048

Singer Jack W

EVP, Chief Medical Officer

• • –

2011-03-25

$0.38

$43,422

D/D

(114,268)

5,954,559

Mundinger Mary Oneil

Director

– • –

2011-03-21

4/A

$0.44

$54,375

D/D

125,000

1,994,849

Bianco Louis A

EVP, Finance & Administration

• – –

2011-03-21

4/A

$0.00

D/D

250,000

6,060,249

Bianco James A

CEO

• • –

2011-03-21

4/A

$0.00

D/D

2,500,000

14,698,638

Philips Craig

President

• – –

2011-03-21

4/A

$0.00

D/D

250,000

9,558,206

Telling Fred

Director

– • –

2011-03-21

4/A

$0.44

$54,375

D/D

125,000

1,712,907

Singer Jack W

EVP, Chief Medical Officer

• • –

2011-03-21

4/A

$0.00

D/D

250,000

6,318,827

Eramian Daniel G

EVP, Corporate Communications

• – –

2011-03-21

4/A

$0.00

D/D

250,000

4,666,899

Nudelman Phillip M Phd

Director

– • –

2011-03-21

4/A

$0.44

$54,375

D/D

125,000

2,359,865

742 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 17 of 30

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: